Cargando…

Treatment Patterns and Outcomes of Elderly Patients With Potentially Curable Esophageal Cancer

OBJECTIVES: The proportion of elderly patients with esophageal cancer (EC) is increasing due to prolonged life expectancy and aging process. The aim of the study is to explore the optimal treatment strategy for elderly patients (aged ≥70 years) with locally advanced EC. METHODS: Eligible patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yang, Chen, Mengyuan, Xie, Jiping, Ji, Yongling, Sheng, Liming, Qiu, Guoqin, Du, Xianghui, Wei, Qichun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882918/
https://www.ncbi.nlm.nih.gov/pubmed/35237508
http://dx.doi.org/10.3389/fonc.2022.778898
_version_ 1784659801187287040
author Yang, Yang
Chen, Mengyuan
Xie, Jiping
Ji, Yongling
Sheng, Liming
Qiu, Guoqin
Du, Xianghui
Wei, Qichun
author_facet Yang, Yang
Chen, Mengyuan
Xie, Jiping
Ji, Yongling
Sheng, Liming
Qiu, Guoqin
Du, Xianghui
Wei, Qichun
author_sort Yang, Yang
collection PubMed
description OBJECTIVES: The proportion of elderly patients with esophageal cancer (EC) is increasing due to prolonged life expectancy and aging process. The aim of the study is to explore the optimal treatment strategy for elderly patients (aged ≥70 years) with locally advanced EC. METHODS: Eligible patients with cT2-4aNxM0 EC were identified in the Surveillance, Epidemiology, and End Results database from 2010 to 2016. Treatment patterns were divided into six groups: surgical resection (S), chemoradiotherapy (CRT), trimodality therapy (CRT+S), radiotherapy (RT), chemotherapy (CT), or observation with no treatment (Obs). Survival between groups was compared using the log-rank test, and the Cox proportional hazards model was used to identify factors associated with overall survival (OS). RESULTS: A total of 2917 patients with potentially curable EC were identified. Of all the patients included, 6.7%, 51.8%, 18.0%, 9.4% and 3.6%received S, CRT, CRT+S, RT, and CT, respectively, whereas 10.6% underwent Obs. The 3-year OS estimates were 30.2% (95% confidence interval [CI]: 23.5–38.9%), 25.4% (95% CI: 22.8–28.3%),44.3% (95% CI: 39.3–49.9%), 11.4% (95% CI: 7.7–17.0%), 16.1% (95% CI: 9.1–28.3%), and 5.6% (95% CI: 3.2–9.8%) for S, CRT, CRT+S RT, CT, and Obs (p<0.001), respectively. Overall, patents underwent CRT+S had the longest OS, compared to other treatment patterns, and the survival difference was not significant between patients receiving CRT and S (p=0.12) in the elderly population. However, the survival benefits of trimodality therapy over CRT gradually weakened with the increase in age, and became statistically non-significant for EC patients aged ≥80 years (p=0.35). Multivariate analysis showed that treatment patterns, age, sex, tumor grade, T stage, N stage, and marital status were significantly associated with OS. CONCLUSION: Generally, the use of trimodality therapy was associated with the longest OS, the survival benefits were comparable between CRT and S alone, and CRT was superior to RT or CT alone in elderly patients with curable EC. For patients intolerable to surgery or aged ≥80 years, definitive CRT should be considered as a preferable option.
format Online
Article
Text
id pubmed-8882918
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88829182022-03-01 Treatment Patterns and Outcomes of Elderly Patients With Potentially Curable Esophageal Cancer Yang, Yang Chen, Mengyuan Xie, Jiping Ji, Yongling Sheng, Liming Qiu, Guoqin Du, Xianghui Wei, Qichun Front Oncol Oncology OBJECTIVES: The proportion of elderly patients with esophageal cancer (EC) is increasing due to prolonged life expectancy and aging process. The aim of the study is to explore the optimal treatment strategy for elderly patients (aged ≥70 years) with locally advanced EC. METHODS: Eligible patients with cT2-4aNxM0 EC were identified in the Surveillance, Epidemiology, and End Results database from 2010 to 2016. Treatment patterns were divided into six groups: surgical resection (S), chemoradiotherapy (CRT), trimodality therapy (CRT+S), radiotherapy (RT), chemotherapy (CT), or observation with no treatment (Obs). Survival between groups was compared using the log-rank test, and the Cox proportional hazards model was used to identify factors associated with overall survival (OS). RESULTS: A total of 2917 patients with potentially curable EC were identified. Of all the patients included, 6.7%, 51.8%, 18.0%, 9.4% and 3.6%received S, CRT, CRT+S, RT, and CT, respectively, whereas 10.6% underwent Obs. The 3-year OS estimates were 30.2% (95% confidence interval [CI]: 23.5–38.9%), 25.4% (95% CI: 22.8–28.3%),44.3% (95% CI: 39.3–49.9%), 11.4% (95% CI: 7.7–17.0%), 16.1% (95% CI: 9.1–28.3%), and 5.6% (95% CI: 3.2–9.8%) for S, CRT, CRT+S RT, CT, and Obs (p<0.001), respectively. Overall, patents underwent CRT+S had the longest OS, compared to other treatment patterns, and the survival difference was not significant between patients receiving CRT and S (p=0.12) in the elderly population. However, the survival benefits of trimodality therapy over CRT gradually weakened with the increase in age, and became statistically non-significant for EC patients aged ≥80 years (p=0.35). Multivariate analysis showed that treatment patterns, age, sex, tumor grade, T stage, N stage, and marital status were significantly associated with OS. CONCLUSION: Generally, the use of trimodality therapy was associated with the longest OS, the survival benefits were comparable between CRT and S alone, and CRT was superior to RT or CT alone in elderly patients with curable EC. For patients intolerable to surgery or aged ≥80 years, definitive CRT should be considered as a preferable option. Frontiers Media S.A. 2022-02-14 /pmc/articles/PMC8882918/ /pubmed/35237508 http://dx.doi.org/10.3389/fonc.2022.778898 Text en Copyright © 2022 Yang, Chen, Xie, Ji, Sheng, Qiu, Du and Wei https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Yang, Yang
Chen, Mengyuan
Xie, Jiping
Ji, Yongling
Sheng, Liming
Qiu, Guoqin
Du, Xianghui
Wei, Qichun
Treatment Patterns and Outcomes of Elderly Patients With Potentially Curable Esophageal Cancer
title Treatment Patterns and Outcomes of Elderly Patients With Potentially Curable Esophageal Cancer
title_full Treatment Patterns and Outcomes of Elderly Patients With Potentially Curable Esophageal Cancer
title_fullStr Treatment Patterns and Outcomes of Elderly Patients With Potentially Curable Esophageal Cancer
title_full_unstemmed Treatment Patterns and Outcomes of Elderly Patients With Potentially Curable Esophageal Cancer
title_short Treatment Patterns and Outcomes of Elderly Patients With Potentially Curable Esophageal Cancer
title_sort treatment patterns and outcomes of elderly patients with potentially curable esophageal cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882918/
https://www.ncbi.nlm.nih.gov/pubmed/35237508
http://dx.doi.org/10.3389/fonc.2022.778898
work_keys_str_mv AT yangyang treatmentpatternsandoutcomesofelderlypatientswithpotentiallycurableesophagealcancer
AT chenmengyuan treatmentpatternsandoutcomesofelderlypatientswithpotentiallycurableesophagealcancer
AT xiejiping treatmentpatternsandoutcomesofelderlypatientswithpotentiallycurableesophagealcancer
AT jiyongling treatmentpatternsandoutcomesofelderlypatientswithpotentiallycurableesophagealcancer
AT shengliming treatmentpatternsandoutcomesofelderlypatientswithpotentiallycurableesophagealcancer
AT qiuguoqin treatmentpatternsandoutcomesofelderlypatientswithpotentiallycurableesophagealcancer
AT duxianghui treatmentpatternsandoutcomesofelderlypatientswithpotentiallycurableesophagealcancer
AT weiqichun treatmentpatternsandoutcomesofelderlypatientswithpotentiallycurableesophagealcancer